Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) YoY EPS Growth: -22.22% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EPS Growth?

Pharmedic Pharmaceutical Medicinal Joint Stock Company HSTC:PMC YoY EPS Growth is -22.22% as of Jun. 2026.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth for the quarter that ended in Jun. 2026 was -22.22%.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was ₫2,843.23.

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EPS Growth Related Terms

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EPS Growth Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.21 28.81 0.18 -4.11 2.71

Pharmedic Pharmaceutical Medicinal Joint Stock Company Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.59 -6.37 20.19 -13.77 -22.22

Pharmedic Pharmaceutical Medicinal Joint Stock Company YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(6437.946-6268.0719)/ | 6268.0719 |
=2.71 %

Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(2843.2285-3655.2863)/ | 3655.2863 |
=-22.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of -22.22% mean?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a YoY EPS Growth of -22.22% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth too high?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's current YoY EPS Growth is -22.22%.
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth compare to IMNPQ?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's YoY EPS Growth of -22.22% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Drug Manufacturers company?
A good YoY EPS Growth depends on the Drug Manufacturers industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors. Pharmedic Pharmaceutical Medicinal Joint Stock Company's current YoY EPS Growth is -22.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company stock overvalued right now?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a current YoY EPS Growth of -22.22%. The current YoY EPS Growth is -22.22%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC), the current YoY EPS Growth is -22.22% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Business Description

Address 367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company (PMC) is a Vietnamese pharmaceutical manufacturer based in Ho Chi Minh City. It develops, produces, and sells branded and generic medicines, cosmetics, and medical supplies for the domestic healthcare market. Its product range spans vitamin and mineral supplements, analgesics, cold and cough preparations, antiseptics, and other over-the-counter and prescription items, marketed under brands such as Farzincol, Povidine, Nacofar, Cooldrop, and Sibemag. Customers include hospitals, clinics, pharmacies, and pharmaceutical distributors, with distribution focused primarily on Vietnam. The company generates revenue mainly through the manufacture and wholesale of its own branded pharmaceutical and personal-care products, supplemented by contract manufacturing and trading of medical supplies. It also operates a network of retail pharmacies in Vietnam.